Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Pfizer’s COVID pill reportedly offered no measurable benefit for adults 40 to 65, according to a study published on Wednesday.

The Israeli study was conducted among 109,000 patients who were 40 years old or older.

READ MORE
 

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

PA Voting Machine Rejected GOP Ballots

Certain voting machines in Pennsylvania were caught completely…
Read more

Israel and Hamas Ceasefire

A ceasefire between Israel and Hamas was reported. The Blaze…
Read more

Pompeo Calls Out China about Wuhan Lab Theory

Former Secretary of State, Mike Pompeo, has called out China…
Read more